
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
CTI Clinical Trial and Consulting Services has signed a Memorandum of Understanding with Samsung Medical Center to affirm their commitments to identifying and developing opportunities for collaboration and cooperation in advancing clinical research in fields such as rare and orphan disease.
To learn more, click






